AngioDynamics (ANGO) Tops Q4 EPS by 3c; Affirms FY18 Outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SPY
8. SWKS
9. XYZ
10. FISV

Go back to AngioDynamics (ANGO) Tops Q4 EPS by 3c; Affirms FY18 Outlook

AngioDynamics Reports Fiscal 2017 Fourth Quarter and Full-Year Results

July 18, 2017 6:00 AM EDT

Company posts record full-year adjusted EPS and Free Cash Flow and issues FY2018 Financial Guidance

Q4 net sales of $86.9 million, down 7% year-over-yearQ4 GAAP loss per share of $0.30; adjusted EPS of $0.19Full Year net sales of $349.6 million, down 1% year-over-yearFull Year GAAP earnings per share of $0.19; Adjusted EPS of $0.73, up 22% compared to FY2016Full Year operating cash generation of $55.7 million; free cash flow generation of $52.7 million

ALBANY, N.Y., July 18, 2017 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ: ANGO), a leading provider of innovative, minimally invasive... More